Hereditary angioedema, emergency management of attacks by a call center

Archive ouverte

Javaud, Nicolas | Altar, Adrien | Fain, Olivier | Reuter, Paul-Georges | Desmaizieres, Michel | Petrovic, Tomislav | Ghazali, Aiham | Durand-Zaleski, Isabelle | Bouillet, Laurence | Vicaut, Eric | Launay, David | Martin, Ludovic | Floccard, Bernard | Gompel, Anne | Sobel, Alain | Boccon-Gibod, Isabelle | Kanny, Gisele | Lapostolle, Frederic | Adnet, Frederic

Edité par CCSD ; Elsevier -

International audience. Objective: Hereditary angiœdema (HAE) is a rare autosomal dominant disease characterized by recurrent, unpredictable, potentially life-threatening swelling. Objective is to assess the management of the acute HAE attacks in the real life setting through a call center in France.Methods: A pre-specified ancillary study of SOS-HAE, a cluster-randomized prospective multicenter trial, was conducted. HAE patients were recruited from 8 participating reference centers. The outcome of interest was the rate of hospitalization.Results: onerhundred patients were included. The median (quartile) age was 38 (29-53) years, and 66 (66%) were female. Eighty (80%) patients had HAE type I, 8 (8%) had HAE type II and 12 (12%) patients had FXII-HAE. Fifty-one (51%) patients had experienced at least one time the call center during the follow-up. Nine over 166 (5%) attacks for 9 different patients resulted in hospital admission to the hospital (in the short-stay unit, ie, <24 h) during the follow-up period. During 2 years, there were 166 calls to call center for 166 attacks. All attacks were treated at home after call center contact.Conclusions: Use of emergency departments and hospitalizations are reduced by the use of a coordinated national call center in HAE after therapeutic education program that promoted self-administration of specific treatment and use of call to call center.Trial registration: clinicalTrials.gov identifier: NCT01679912.

Suggestions

Du même auteur

Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial

Archive ouverte | Floccard, Bernard | CCSD

International audience. STUDY OBJECTIVE: Hereditary angioedema is a rare disease associated with unpredictable, recurrent attacks of potentially life-threatening edema. Management of severe attacks is currently subo...

Hereditary Angioedema, Clinical Presentation and Socio-Economic Cost of 200 French Patients

Archive ouverte | Javaud, Nicolas | CCSD

International audience

Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial

Archive ouverte | Javaud, Nicolas | CCSD

International audience. Introduction This study protocol describes a trial designed to investigate whether antihistamine alone in patients with acute urticaria does not increase the 7-day Urticaria Activity Score (U...

Chargement des enrichissements...